Studies have shown increased levels of TNF-α in the skin tissues and blood samples of contact dermatitis and psoriasis patients86,87, and treatments that inhibit activation of TNF-α display significant efficacy in both contact dermatitis and psoriasis88–91. The gene discussed is TNF; the disease is psoriasis.